Aptorum Group Limited
Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) is a pharmaceutical company dedicated to developing and commercializing novel therapeutics to tackle unmet medical needs. Aptorum Group is pursuing therapeutic projects in orphan diseases, infectious diseases, metabolic diseases, woman’s health and other disease areas.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Globally (various continents)
This company also provides solutions for other industrial applications.
Please, visit the following links for more info:
About Us
At Aptorum, we believe that by facilitating the development of medical innovations, particularly in those that able to meet current unmet medical needs and significantly improve clinical and surgical experience, is inevitable in advancing the quality of human life and patient care. With this vision, Mr. Ian Huen founded Aptorum, leveraging the region’s talented specialists and prosperous medical resources, to accelerate the evolution of potentially First-in-Class/Best-in-Class therapeutic and diagnostic innovations across a wide range of disease areas. By combining a broad project portfolio of preclinical stage novel medical innovations and multi-disciplinary human capital, Aptorum aims to become a world class player in the biopharmaceutical industry with emphasis in science, collaboration and entrepreneurship.